Tatva Chintan Pharma Chem Q1 Results Live : profit falls by 45.19% YOY
Tatva Chintan Pharma Chem Q1 Results Live : Revenue decreased by 7.78% YoY & profit decreased by 45.19% YoY
Tatva Chintan Pharma Chem Q1 Results Live : Tatva Chintan Pharma Chem declared their Q1 results on 24 Jul, 2024. The topline decreased by 7.78% & the profit decreased by 45.19% YoY. As compared to the previous quarter the revenue grew by 7.33% and the profit decreased by 45.82%.
The Selling, general & administrative expenses declined by 11.63% q-o-q & increased by 9.8% Y-o-Y.
The operating income was down by 36.54% q-o-q & decreased by 61.19% Y-o-Y.
The EPS is ₹2.23 for Q1 which decreased by 48.02% Y-o-Y.
Tatva Chintan Pharma Chem has delivered -11.46% return in the last 1 week, -27.39% return in last 6 months and -38.11% YTD return.
Currently the Tatva Chintan Pharma Chem has a market cap of ₹2318.85 Cr and 52wk high/low of ₹1772.4 & ₹956.7 respectively.
As of 26 Jul, 2024 out of 5 analysts covering the company, 1 analyst has given Sell rating, 2 analysts have given Hold rating &2 analysts have given Strong Buy rating.
Tatva Chintan Pharma Chem Financials
| Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 105.46 | 98.27 | +7.33% | 114.36 | -7.78% |
| Selling/ General/ Admin Expenses Total | 12.7 | 14.37 | -11.63% | 11.56 | +9.8% |
| Depreciation/ Amortization | 6.67 | 6.23 | +6.93% | 6.01 | +10.86% |
| Total Operating Expense | 99.51 | 88.89 | +11.95% | 99.03 | +0.49% |
| Operating Income | 5.95 | 9.38 | -36.54% | 15.33 | -61.19% |
| Net Income Before Taxes | 6.81 | 13.69 | -50.26% | 13.42 | -49.26% |
| Net Income | 5.21 | 9.61 | -45.82% | 9.5 | -45.19% |
| Diluted Normalized EPS | 2.23 | 4.11 | -45.74% | 4.29 | -48.02% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
- Top Gainers
- Top Losers
- 52 Week High